Implementing a Standardized Educational Tool for Patients With Brain Tumors Undergoing Concurrent Temozolomide and Radiation Therapy
Data analysis from the administered Brief Adherence Rating Scale demonstrated a mean of 99.3% (N = 13) medication adherence among participants. Median medication adherence was demonstrated to be 100%, with scores ranging from 93% to 100%.
Authors
- Jennifer C Stewart
Institutions
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Clinical journal of oncology nursing
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1188/24.cjon.477-482
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00